Keywords: icn, pharma, set, spend, pharmaceuticals, says, plans

ICN Pharma set to spend more on R&D

Article | 27 January 2000

Print This

ICN Pharmaceuticals says that it plans to reinvest "a large part of itsgrowing royalty stream," from Schering-Plough's sales of Rebetron ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in